Product image of Lazcluze 240 mg (Lazertinib) 240mg Tablet supplied by GNH India

Lazcluze 240 mg

Active Ingredient:
Lazertinib
Form:
Tablet
Brand:
LAZCLUZE 240 MG
Origin:
USA

Lazcluze 240 mg (Lazertinib Tablet) 240mg

LAZCLUZE 240 MG contains lazertinib, a prescription tablet used for targeted therapy in certain cancer treatments. This EGFR inhibitor helps manage specific tumor growths by blocking signals that promote cancer cell proliferation. Store at room temperature and keep out of reach of children.

Strength

240mg

Pack Size

60s

Storage

15-25°

Manufacturer / TM Owner

Janssen Biotech, Inc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • LAZCLUZE 240 MG is primarily used in the treatment of non-small cell lung cancer (NSCLC) with specific genetic mutations. It belongs to a class of medications called tyrosine kinase inhibitors, which work by targeting and blocking proteins that encourage cancer cell growth. Patients prescribed this medication typically have EGFR mutations, making it a key option in precision oncology.

Side Effects

  • LAZCLUZE 240 MG may help reduce tumor size and slow disease progression in eligible patients. Common effects include mild gastrointestinal discomfort, skin reactions, or fatigue, which vary by individual. Some users report improved breathing or reduced symptoms related to their condition during treatment.

Precautions & Warnings

  • Store LAZCLUZE 240 MG at room temperature (15–25°C) and protect it from moisture and direct light. Keep the medication in its original packaging until ready to use. Always handle with care, and avoid crushing or splitting tablets unless advised by a healthcare professional. Wash hands after handling.

Avoid Interactions

  • LAZCLUZE 240 MG may interact with strong CYP3A4 inhibitors or inducers, altering its effectiveness. Avoid grapefruit products, as they can increase drug levels in the blood. Consult a healthcare provider before combining with other medications, including over-the-counter drugs or supplements, to prevent potential interactions.

Frequently Asked Questions

Lazertinib is used to treat certain types of non-small cell lung cancer with specific genetic mutations.

Store at room temperature (15–25°C) in a dry place, away from light and moisture.

Follow your healthcare provider’s instructions regarding food intake with this medication.

Common effects may include skin reactions, fatigue, or mild gastrointestinal discomfort.

No, it is a targeted therapy medication, specifically a tyrosine kinase inhibitor.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lazertinib

Leclaza 80mg

Leclaza 80mg

80mg Tablet
Lazcluze 80 mg

Lazcluze 80 mg

80mg Tablet
Leclaza 80mg

Leclaza 80mg

80mg Tablet

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT